Drug discovery

#Drug discovery

App Note: Fcγ Receptor and Antigen Kinetic Screening for Rapid Biosimilar Downstream Processing Assessment

Demonstrating similarity of biomolecules such as antibodies throughout upstream and downstream production processes is crucial. A rapid testing method is demonstrated using a Humira® biosimilar (adalimumab) development sample, which assesses compatibility with three essential ligands in compliance with regulatory standards. This Application Note covers: How to rapidly assess column… Read More

#App Notes

Team of scientists in the lab
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: How to collaborate effectively across multiple teams

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

Biosafety cabinet
#Automation / robotics #Biosafety testing #Drug discovery #Whitepaper

Whitepaper: Ensure your automation equipment is protected

A new whitepaper is now available from NuAire entitled ‘Bespoke Biosafety: Building a Custom Biosafety Cabinet Around your Laboratory Automation Equipment’. Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases,… Read More

#News

#Automation / robotics #Biosafety testing #Drug discovery

Bespoke biosafety: Building a custom biosafety cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Resources

#Assay development optimisation & technology #Assays #Collaborative Drug Discovery (CDD) #Drug development #Drug discovery

How improved assay analysis benefits early drug discovery

DDW Editor Reece Armstrong speaks to Abraham Wang, Head of Marketing at Collaborative Drug Discovery (CDD) about annotated assays and the advantages they bring to research teams. RA: What advantages can better analysis into assays bring to drug developers? AW: Better analysis into assays offers a… Read More

#Exclusive Content

Sustainability concept
#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Improve sustainability without compromising on quality

A new Feature Note is now available entitled ‘Sustainability in the Lab: A Step-by-Step Guide‘, brought to you by PHCbi. Download the guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing… Read More

#News

#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Sustainability in the Lab: A Step-by-Step Guide

Download this guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing the right equipment Conserving water and reducing waste Engaging and educating your team… Read More

#Resources

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Enhancing collaboration in drug discovery: Register now

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

A team working in a laboratory
#Biotech #Collaboration #Drug discovery #Lab technology #Torx Software #Webinar

Enhancing collaboration in drug discovery – a biotech perspective

Delivery of synthesis targets within small molecule drug discovery often involves many chemists and other collaborators, both internal and external, across multiple locations. Harnessing skills and knowledge from distributed teams can create challenges for efficiently managing the ideation process and prioritisation, assignment and delivery of agreed targets. Read More

Webinar date:
Brought to you by Cresset
#Webinars

#Drug discovery

Webinar: Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance 26.02.2024

In this webinar, hosted by DDW and sponsored by Thermo Fisher Scientific, we examine focused environmental monitoring within a cGMP facility. Specifically, leveraging the Applied Biosystems MicroSEQ Microbial Identification System in biotherapeutic manufacturing.  Microbial control within biopharmaceutical manufacturing is a critical quality control to help ensure drug products are free… Read More

#Webinars

#ALS #Drug discovery #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells

Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages. Download the whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype… Read More

#Resources

GBP pound sterling funding
#Alentis Therapeutics #Curve Therapeutics #Drug discovery #Finance #Funding #Pfizer Ventures #Seed funding #Solid tumours

£40.5 million invested in discovery platform and to advance pipeline 

Curve Therapeutics, a company developing an intracellular screening platform to address disease targets, has completed a £40.5 million ($51.37 million) Series A financing round. Pfizer Ventures led the round with participation from Columbus Venture Partners and British Patient Capital, which join founding investor Advent Life Sciences and… Read More

#News

#Automation / robotics #Drug discovery

Whitepaper: Bespoke Biosafety: Building a Custom Biosafety Cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Whitepapers

Gene editing concept
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

New eBook: What does the future hold for gene editing & CRISPR?

Following the first regulatory approval of a CRISPR-based drug in late 2023, over ten years since the CRISPR-Cas9 system was elucidated, there is considerable optimism about the future potential for gene editing technologies. The astonishing pace of innovation has led to new, potentially safer CRISPR-based techniques, including… Read More

#News

CRISPR eBook cover
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

Gene editing & CRISPR: Advances in applications and opportunity

This eBook explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future. Download this exclusive eBook to learn more about: How CRISPR is providing new solutions for common diseases; The potential of base editing… Read More

#DDW eBooks #Intelligence

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Achieve future success in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News